470 related articles for article (PubMed ID: 15800694)
1. Genetic factors in pancreatitis.
Grigorescu M; Grigorescu MD
Rom J Gastroenterol; 2005 Mar; 14(1):53-61. PubMed ID: 15800694
[TBL] [Abstract][Full Text] [Related]
2. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis.
Audrézet MP; Chen JM; Le Maréchal C; Ruszniewski P; Robaszkiewicz M; Raguénès O; Quéré I; Scotet V; Férec C
Eur J Hum Genet; 2002 Feb; 10(2):100-6. PubMed ID: 11938439
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of SPINK mutations in pancreatic development and disease.
Liddle RA
Endocrinol Metab Clin North Am; 2006 Jun; 35(2):345-56, x. PubMed ID: 16632097
[TBL] [Abstract][Full Text] [Related]
4. Genetic aspects of chronic pancreatitis.
Teich N; Mössner J
Med Sci Monit; 2004 Dec; 10(12):RA325-8. PubMed ID: 15567996
[TBL] [Abstract][Full Text] [Related]
5. CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients.
Bernardino AL; Guarita DR; Mott CB; Pedroso MR; Machado MC; Laudanna AA; Tani CM; Almeida FL; Zatz M
JOP; 2003 Sep; 4(5):169-77. PubMed ID: 14526128
[TBL] [Abstract][Full Text] [Related]
6. Hereditary chronic pancreatitis.
Teich N; Mössner J
Best Pract Res Clin Gastroenterol; 2008; 22(1):115-30. PubMed ID: 18206817
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene (SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis.
Tzetis M; Kaliakatsos M; Fotoulaki M; Papatheodorou A; Doudounakis S; Tsezou A; Makrythanasis P; Kanavakis E; Nousia-Arvanitakis S
Clin Genet; 2007 May; 71(5):451-7. PubMed ID: 17489851
[TBL] [Abstract][Full Text] [Related]
8. Germline mutations and gene polymorphism associated with human pancreatitis.
Weiss FU; Simon P; Mayerle J; Kraft M; Lerch MM
Endocrinol Metab Clin North Am; 2006 Jun; 35(2):289-302, viii-ix. PubMed ID: 16632093
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenetic concepts of chronic pancreatitis].
Teich N; Keim V
Zentralbl Chir; 2001 Nov; 126(11):884-8. PubMed ID: 11753798
[TBL] [Abstract][Full Text] [Related]
10. Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis.
Sobczyńska-Tomaszewska A; Bak D; Oralewska B; Oracz G; Norek A; Czerska K; Mazurczak T; Teisseyre M; Socha J; Zagulski M; Bal J
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):299-306. PubMed ID: 16954950
[TBL] [Abstract][Full Text] [Related]
11. Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis.
Keiles S; Kammesheidt A
Pancreas; 2006 Oct; 33(3):221-7. PubMed ID: 17003641
[TBL] [Abstract][Full Text] [Related]
12. The role of cystic fibrosis gene mutations in determining susceptibility to chronic pancreatitis.
Cohn JA; Mitchell RM; Jowell PS
Gastroenterol Clin North Am; 2004 Dec; 33(4):817-37, vii. PubMed ID: 15528020
[TBL] [Abstract][Full Text] [Related]
13. Hereditary chronic pancreatitis.
Rosendahl J; Bödeker H; Mössner J; Teich N
Orphanet J Rare Dis; 2007 Jan; 2():1. PubMed ID: 17204147
[TBL] [Abstract][Full Text] [Related]
14. Hereditary pancreatitis in children: surgical implications with special regard to genetic background.
Schmitt F; Le Henaff G; Piloquet H; Leclair MD; David A; Heloury Y; Podevin G
J Pediatr Surg; 2009 Nov; 44(11):2078-82. PubMed ID: 19944211
[TBL] [Abstract][Full Text] [Related]
15. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.
Felderbauer P; Karakas E; Fendrich V; Bulut K; Horn T; Lebert R; Holland-Letz T; Schmitz F; Bartsch D; Schmidt WE
Am J Gastroenterol; 2008 Feb; 103(2):368-74. PubMed ID: 18076731
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis.
Perri F; Piepoli A; Stanziale P; Merla A; Zelante L; Andriulli A
Eur J Hum Genet; 2003 Sep; 11(9):687-92. PubMed ID: 12939655
[TBL] [Abstract][Full Text] [Related]
17. The impact of cystic fibrosis and PSTI/SPINK1 gene mutations on susceptibility to chronic pancreatitis.
Cohn JA; Mitchell RM; Jowell PS
Clin Lab Med; 2005 Mar; 25(1):79-100. PubMed ID: 15749233
[TBL] [Abstract][Full Text] [Related]
18. Genetic aspects of chronic pancreatitis: insights into aetiopathogenesis and clinical implications.
Truninger K; Ammann RW; Blum HE; Witt H
Swiss Med Wkly; 2001 Oct; 131(39-40):565-74. PubMed ID: 11775491
[TBL] [Abstract][Full Text] [Related]
19. Genetic counseling for hereditary pancreatitis--the role of molecular genetics testing for the cationic trypsinogen gene, cystic fibrosis and serine protease inhibitor Kazal type 1.
Ellis I
Gastroenterol Clin North Am; 2004 Dec; 33(4):839-54. PubMed ID: 15528021
[TBL] [Abstract][Full Text] [Related]
20. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
